A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Song ChenQin YinHuibo ShiDunfeng DuSheng ChangLi NiHaifang QiuZhishui ChenJixian ZhangWeijie ZhangPublished in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2020)
In December 2019, an outbreak of COVID-19 occurred in Wuhan, China, and spread to the whole of China and to multiple countries worldwide. Unlike SARS and MERS, where secondary transmission mostly occurred in hospital settings, COVID-19 transmission occurs in large numbers within families. Herein we report three cases of a familial cluster with one family member being a kidney transplant recipient. The initial clinical symptoms of COVID-19 in these three patients were the same, but their progression was different. Based on the severity of clinical symptoms, chest computer tomography findings and SARS-Cov-2 RNA test results, we admitted the husband to the respiratory intensive care unit (RICU) and used a treatment consisting of immunosuppressant reduction/cessation and low dose methylprednisolone-based therapy, and his wife to the respiratory isolation ward. In contrast, the son received in-home isolation and home-based care. All three family members made a full recovery.
Keyphrases
- coronavirus disease
- sars cov
- respiratory syndrome coronavirus
- intensive care unit
- low dose
- healthcare
- end stage renal disease
- high dose
- ejection fraction
- magnetic resonance
- newly diagnosed
- early onset
- emergency department
- palliative care
- physical activity
- machine learning
- pain management
- sleep quality
- mesenchymal stem cells
- bone marrow
- chronic pain
- contrast enhanced
- depressive symptoms
- replacement therapy